Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86,559,040
-
Total 13F shares
-
54,572,890
-
Share change
-
-1,028,787
-
Total reported value
-
$948,388,792
-
Put/Call ratio
-
0%
-
Price per share
-
$17.38
-
Number of holders
-
136
-
Value change
-
-$36,428,045
-
Number of buys
-
78
-
Number of sells
-
51
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q1 2022
As of 31 Mar 2022,
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) was held by
136 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,572,890 shares.
The largest 10 holders included
Avidity Partners Management LP, BlackRock Inc., Frazier Life Sciences Management, L.P., Nantahala Capital Management, LLC, VANGUARD GROUP INC, BVF INC/IL, STATE STREET CORP, Avoro Capital Advisors LLC, ORBIMED ADVISORS LLC, and PFM Health Sciences, LP.
This page lists
136
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.